Stomach Adenocarcinoma

• CLINICAL_TRIALS withdrawal · 2025-12-26
  Clinical Trial Update: Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma [Phase 2]

  A Phase 2 trial of zimberelimab plus domvanalimab in stomach and gastroesophageal junction adenocarcinoma has been withdrawn.

• CLINICAL_TRIALS trial_result · 2025-06-18
  Clinical Trial Update: Preoperative HFRT Verses PULSAR for Locally Advanced GEJ or Proximal Gastric Adenocarcinoma [Phase 2]

  A Phase 2 trial comparing preoperative hypofractionated radiotherapy (HFRT) versus the PULSAR approach for locally advanced gastroesophageal…

• CLINICAL_TRIALS research · 2025-06-12
  Clinical Trial Update: Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer [Phase 2]

  Phase 2 neoadjuvant study evaluating nab-paclitaxel, oxaliplatin, S-1, and sintilimab in early-onset resectable gastric cancer; currently no…

• CLINICAL_TRIALS trial_result · 2023-02-01
  Clinical Trial Update: Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma [Phase 1, Phase 2]

  Clinical trial update for a combination therapy (rucaparib + ramucirumab with or without nivolumab) in advanced gastric and esophageal adeno…

• CLINICAL_TRIALS trial_result · 2020-02-11
  Clinical Trial Update: Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]

  Phase 2 trial evaluating conversion therapy with sintilimab plus CAPOX in unresectable locally advanced or limited metastatic stomach/EGJ ad…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2018-07-13
  Clinical Trial Update: A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach [Phase 2]

  This Phase 2 trial evaluating perioperative mFOLFOX6 plus pembrolizumab for potentially resectable gastroesophageal junction and stomach ade…

• CLINICAL_TRIALS research · 2014-07-18
  Clinical Trial Update: Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach [Phase 3]

  Phase 3 intergroup trial evaluating adjuvant chemotherapy for stomach and gastroesophageal junction adenocarcinoma has completed.

• CLINICAL_TRIALS research · 2013-10-14
  Clinical Trial Update: Early Oral Feeding After Total Gastrectomy for Cancer [NA]

  An update on a clinical trial evaluating early oral feeding after total gastrectomy in patients with stomach cancer.